Medically reviewed and approved by a board-certified member
Acid Reflux / GERD

Setting the record straight: Proton-pump inhibitors (PPIs) do not cause dementia

BS Media
By BS Media
Published: Sunday, 23 July 2017
BS
Login to get unlimited free access
Be the first to comment!

Several studies have according associations between proton-pump substance (PPI) use and dementedness. New research published in medicine, the official journal of the American Gastroenterological Association (AGA), puts these claims to rest. The study authors report that there is no credible evidence to support the suggestion that PPI use increases dementedness risk. These collection are based on an analysis of 13,864 participants from the Nurses' Health Study II who completed testing on psychological feature function, which is key predictor of the risk of dementedness later in life.

PPIs are wide prescribed for the treatment of acid-related upper GI disorders, so much as internal organ reflux illness (GERD). piece PPIs are best-known to effectively treat these conditions, they have received negative publicity in recent years as research has associated PPIs with several adverse outcomes.

"One of the most common questions gastroenterologists receive from their patients is whether PPIs are safe to use, based on the distressing headlines linking PPIs to everything from hip fracture, to dementedness, to death," aforesaid study author Andrew T. Chan, MD, MPH, an expert of the American Gastroenterological Association from Massachusetts General Hospital and Harvard Medical School, Boston. "Our new research should provide some support to individuals who require these extremely effective medications for long-run treatment."

This research directly responds to a 2016 pharmacoepidemiologic analysis conducted exploitation a large German health insurance information, which known an association between dementedness and long-run PPI use; nevertheless, these collection could not illustrate that PPIs caused dementedness. Despite the attention this article received at the time, AGA expressed its concerns on this research at the time of publication.

Three important reminders for patients taking PPIs:

  1. Talk to your doctor before making any changes to your medication. You have been prescribed PPIs for a reason, to treat a diagnosed medical condition. You and your doctor can discuss the reason for your prescription, the dose and the timeframe for treatment.
  2. Consider life style modifications that may reduce or eliminate the need for PPIs for long-run use. These may include weight loss, avoiding tobacco or a change in your feeding patterns. Your doctor can help you determine the changes that are right for you.
  3. Keep in touch with your doctor. Research continues to be done on PPI use. piece the latest research and headlines on PPIs may seem chilling, current research still recommends that patients who have a diagnosed condition that is helped by PPIs should stay on them, as benefits can outweigh risks.

Article: Association Between nucleon Pump substance Use and psychological feature Function in Women, Andrew T. Chan et al., medicine, doi: 10.1053/j.gastro.2017.06.061, published online 18 July 2017.

Was this page helpful?
(0 votes)
Setting the record straight: Proton-pump inhibitors (PPIs) do not cause dementia
End of the article